Stable Protein Formulations

Abstract

Described herein are stable protein solutions having a pH of about 3.5 to about 7.0 and being stable against protein precipitation, as well as methods for producing such stable protein solutions, and beverages and beverage additives for human or animal consumption containing such stable protein solutions. These stable protein solutions contain a protein, a stabilizer, and a protein deamidase.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims the benefit of priority to U.S. Provisional Application No. 62 / 810,891, filed February 26, 2019, the entire contents of which are incorporated herein by reference. [Technical field]

[0002] Described herein are stable protein solutions having a pH of 7 or less that are stable against protein precipitation, and methods for making such stable protein solutions and their use in beverages or beverage additives. [Background technology]

[0003] There is an increasing demand for protein-rich food products, as well as protein-rich vegetarian and vegan products. In particular, there is an increasing demand for protein-rich beverages and beverage additives, including vegetable proteins and other non-animal proteins. However, it is difficult to incorporate such proteins into solutions, especially solutions with a pH of 7 or less, which are common in beverages, because the solubility of such proteins is limited at pH 7 or less. Therefore, there is a need for protein solutions that are stable against protein precipitation at pH 7 or less. Summary of the Invention

[0004] Provided herein is a stable protein solution comprising (i) a protein, (ii) a stabilizer, and (iii) a protein deamidase, the protein solution having a pH of about 3.5 to about 7.0 and stable against protein precipitation. In some embodiments, the solution comprises (i) about 0.1% to about 30% w / v protein based on the volume of the solution, (ii) about 0.001% to about 5% w / v stabilizer based on the volume of the solution, and (iii) about 0.5 U to about 50 U protein deamidase activity or about 0.1% to about 10% w / w protein deamidase based on the weight of the protein in the solution. In some embodiments, the solution comprises (i) about 0.1% to about 30% w / v protein by volume of the solution, (ii) about 0.001% to about 1% w / v stabilizer by volume of the solution, and (iii) about 5 U to about 50 U protein deamidase activity or about 1% to about 10% w / w protein deamidase by weight of protein in the solution. In some embodiments, the solution comprises about 5% to about 15% w / v protein by volume of the solution. In some embodiments, the solution comprises about 0.02% to about 0.5% w / v stabilizer by volume of the solution. In some embodiments, the solution comprises about 1% w / w to about 5% w / w protein deamidase by weight of protein in the solution.

[0005] In some embodiments, the protein comprises one or more selected from vegetable proteins (e.g., soy, pea, lentil, chickpea, legume, hemp, rice, nut, wheat, and gluten proteins (including peanut protein and almond protein)), milk proteins (e.g., whey proteins), and insect proteins (e.g., one or more of cricket, mole cricket, silkworm, sago worm, grasshopper, scorpion, diving beetle, German cockroach, earthworm, mealworm, and spider protein).

[0006] In some embodiments, the stabilizer comprises one or more gums, polysaccharides, and collagens, such as one or more of xanthan gum, gellan gum, carrageenan gum, cassia gum, locust bean gum, tara gum, psyllium seed gum, gelatin, tamarind seed gum, gum arabic, alginate, propylene glycol alginate, pectin, galactomannan (guar gum), pullulan, methylcellulose (MC), carboxymethylcellulose (CMC), and any derivatives or combinations thereof.

[0007] In some embodiments, the protein deamidase is, for example, a protein glutaminase deamidase or a protein asparaginase deamidase that deamidates amide groups of asparagine and / or glutamine residues of proteins. In some embodiments, the protein deamidase is produced by a bacterium selected from Chryseobacterium, Flavobacterium, Enpedobacter, Sphingobacterium, Aureobacterium, Myroides, Cytophagales, Actinomycetes, and Flavobacteriaceae. In some embodiments, the protein deamidase is produced by a Penicillium microorganism. In some embodiments, the protein deamidase is protein glutaminase deamidase, Protein Glutaminase Amano 500 (PGA500). In some embodiments, the protein deamidase comprises the amino acid sequence of SEQ ID NO: 1 (which is a protein glutaminase deamidase), or a sequence having at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, or at least 99% identity thereto and having protein deamidase activity. In some embodiments, the protein deamidase comprises a mutant amino acid sequence of SEQ ID NO: 1 having one or more substitutions or deletions at amino acid residues 35, 38-43, 45, 46, 49, 79-84, 103-106, 117, 142, 143, 146, 166, or 185 of SEQ ID NO: 1.In some embodiments, the protein deamidase comprises a mutant amino acid sequence of SEQ ID NO:1 that is at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, or at least 99% identical to SEQ ID NO:1 and has one or more substitutions or deletions at amino acid residues 35, 38-43, 45, 46, 49, 79-84, 103-106, 117, 142, 143, 146, 166, or 185 of SEQ ID NO:1, and has protein deamidase activity.

[0008] In some embodiments, the solution has a pH of about 4.0 to about 7.0 or about 4.0 to about 5.0.

[0009] In some embodiments, the solution is stable to visible precipitation of protein after storage at 4° C. for a period selected from 7 days, 14 days, 21 days, 1 month, 2 months, and 6 months (including 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, and 12 months).

[0010] In some embodiments, the solution is formulated as a beverage or beverage additive for human or animal consumption.

[0011] Also provided is a beverage or beverage additive for human or animal consumption comprising the stable protein solution described herein. In some embodiments, the beverage or beverage additive is selected from nutritional beverages, sports beverages, functional protein beverages, dairy beverages, dairy smoothies, fruit beverages, fruit smoothies, coffee beverages, tea beverages, vegetable milks, dairy creamers, and non-dairy creamers. In some embodiments, the beverage or beverage additive comprises one or more acidic or fruit juices, or acidic or fruit juice concentrates. In some embodiments, the beverage or beverage additive comprises one or more vegetable juices or vegetable concentrates. In some embodiments, the beverage or beverage additive comprises one or more acidic or vegetable juices, or acidic or vegetable juice concentrates.

[0012] Also provided is a method of producing a stable protein solution as described herein, or a beverage or beverage additive as described herein, comprising: (a) adding a protein deamidase to a solution comprising a protein and a stabilizer to obtain a mixture; (b) incubating the mixture; and (c) acidifying the mixture to obtain a solution having a pH of about 3.5 to about 7.0. In some embodiments, the solution is prepared by mixing (i) a solution comprising a protein and (ii) a solution comprising a stabilizer. In some embodiments, the incubation is performed until the enzymatic reaction reaches a desired level of completion, which is optionally determined by the concentration of free ammonium ions in the solution. In some embodiments, the incubation is performed at a temperature of about 30° C. to about 70° C., for about 0.5 hours to about 48 hours, optionally with stirring, and optionally at a pH of about 3.0 to about 8.0. In some embodiments, the incubation is performed at a temperature of about 40° C. to about 60° C., for about 3 hours to about 24 hours, optionally with stirring, and optionally at a pH of about 5.0 to about 8.0. In some embodiments, acidification comprises the addition of an acidic juice or juice concentrate. In some embodiments, the protein deamidase is Protein Glutaminase Amano 500 (PGA500) and / or one having the amino acid sequence of SEQ ID NO:1 as described herein or a variant thereof, and incubation is at 50° C. for 3 hours.

[0013] In some embodiments, the process further comprises subjecting the solution to a heat treatment at about 85° C. for about 10 minutes. In some embodiments, the process further comprises subjecting the solution to one or more treatments selected from homogenization, pasteurization, and sterilization. In some embodiments, homogenization is performed at a pressure of about 2,000 psi to about 20,000 psi, including about 2,000 psi to about 2,500 psi. In some embodiments, pasteurization is performed using high temperature short time (HTST) pasteurization at about 100° C. for about 10 seconds to about 20 seconds, ultra high temperature (UHT) pasteurization at about 120° C. for about 1 second to about 3 seconds, or low temperature long time (LTLT) pasteurization at about 75° C. to about 85° C. for about 10 minutes to about 20 minutes. In some embodiments, sterilization is performed using high pressure (high specific gravity) sterilization. [Brief description of the drawings]

[0014] [Figure 1] FIG. 1 shows absorbance based on pH for pea protein formulations (i) with protein glutaminase deamidase and gums, (ii) with protein glutaminase deamidase, (iii) with gums, and (iv) without protein glutaminase deamidase and gums. [Diagram 2] FIG. 1 shows absorbance based on pH for soy protein formulations (i) with protein glutaminase deamidase and a gum, (ii) with protein glutaminase deamidase, (iii) with a gum, and (iv) without protein glutaminase deamidase and a gum. [Diagram 3] FIG. 1 shows the absorbance based on pH of hemp protein formulations (i) with protein glutaminase deamidase and gums, (ii) with protein glutaminase deamidase, (iii) with gums, and (iv) without protein glutaminase deamidase and gums. [Figure 4]FIG. 1 shows the absorbance based on pH of peanut protein formulations (i) with protein glutaminase deamidase and gum, (ii) with protein glutaminase deamidase, (iii) with gum, and (iv) without protein glutaminase deamidase and gum. [Diagram 5] FIG. 1 shows the absorbance based on pH of cricket protein formulations (i) with protein glutaminase deamidase and gum, (ii) with protein glutaminase deamidase, (iii) with gum, and (iv) without protein glutaminase deamidase and gum. [Figure 6] 1 shows the absorbance of homogenized pea protein formulations (i) with glutaminase deamidase and gums, and (ii) with gums only (without glutaminase deamidase). [Figure 7] 1 shows the absorbance of homogenized soy protein formulations with juice concentrate with (i) glutaminase deamidase and gums, and (ii) gums only (no glutaminase deamidase). [Figure 8] 1 shows the absorbance of homogenized peanut protein formulations with juice concentrate with (i) glutaminase deamidase and gums, and (ii) gums only (no glutaminase deamidase). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0015] definition The technical and scientific terms used herein have the meanings that are commonly understood by those skilled in the art to which this disclosure pertains, unless otherwise defined. Various methods known to those skilled in the art are referred to herein. Suitable materials and / or methods known to those skilled in the art can be utilized in carrying out this disclosure. However, certain materials and methods are described for illustrative purposes only. Materials, reagents, etc. referred to in the following description and examples can be obtained from commercial sources unless otherwise specified.

[0016] As used herein, the singular forms "a," "an," and "the" designate both the singular and the plural, unless expressly stated to designate only the singular.

[0017] As used herein, the term "about" is meant to include values ​​around the recited number or range without limiting the number or range to the exact number or range stated, but as would be understood by one of ordinary skill in the art depending on the context in which the number or range is used. Unless otherwise clear from the context or practice in the art, "about" means up to plus or minus 10% of the particular term.

[0018] Described herein are stable protein solutions comprising a protein, a stabilizer, and a protein deamidase, the protein solutions having a pH of about 3.5 to about 7.0 and being stable against protein precipitation. Described herein are beverages and beverage additives comprising such solutions. Described herein are methods of making such stable protein solutions, and beverages or beverage additives comprising them.

[0019] As used herein, "stable to protein precipitation" means the absence of visible protein precipitation. In some embodiments, the absence of visible precipitation is confirmed by assessing absorbance at about 280 nm, where an increase in absorbance correlates with protein solubilization and the absence of precipitation. For solutions having protein concentrations described herein (without precipitation), typical absorbance at about 280 nm ranges from about 8-50 mg protein / mL.

[0020] The stable protein solutions described herein address the challenge of protein formulation in solutions at or below pH 7, a common pH for beverages and beverage additives. For example, many beverages, including functional and sports beverages, contain fruit and / or vegetable juices or juice flavors and have a pH of 7 or below, e.g., about 7 to about 3.5. When proteins are formulated into such beverages, they tend to precipitate out of solution, resulting in sedimentation. Without being bound by theory, it is believed that this precipitation occurs because the pH of the beverage is close to the isoelectric point of the protein, causing the protein to destabilize and its precipitation and settling. In addition to being unacceptable to consumers, protein precipitation limits flavor masking options and other formulation options. The stability of the solutions described herein at acidic pH allows for the incorporation of acidic juices, such as fruit juices, into the protein solutions. As shown in the examples below, the solutions described herein are stable to precipitation even at acidic pH. Thus, the solutions described herein allow for the incorporation of protein solutions into or with acidic juices, such as fruit juices, to provide, for example, protein-containing fruit juice-based or fruit-flavored or fruit juice-flavored beverages or beverage additives.

[0021] The stable protein solutions described herein use a unique combination of protein deamidating enzymes and stabilizers to address this challenge. Protease enzymes have been used previously, but their use is limited by the formation of compounds with undesirable flavors resulting from enzymatic degradation of the substrate protein. Certain gum stabilizers and emulsifiers have been used previously, but they are only effective at high concentrations (e.g., 2-5% w / v) where they exert other undesirable effects such as coagulation, stratification, and even precipitation. Furthermore, the use of stabilizers at these high concentrations results in a final product with a high viscosity that is undesirable to consumers. In contrast, the solutions described herein have acceptable viscosity characteristics for use in or as beverages and beverage additives, e.g., viscosities in the range of about 10 to about 250 mPa·s. (For reference, milk has a viscosity of about 2-3 mPa·s, most vegetable oils have a viscosity of about 40-50 mPa·s, and chocolate sauce may have a viscosity of 280 mPa·s.)

[0022] Without being bound by theory, it is believed that the protein deamidases described herein deamidate amino acid residues, such as glutamine and / or asparagine residues, in proteins, thereby increasing the negative charge of the protein, decreasing the isoelectric point of the protein, and increasing its solubility at acidic pH values. As a result, protein solubility at acidic pH is improved. Also, without being bound by theory, certain protein deamidases described herein increase protein solubility without producing undesirable flavor compounds by deamidating proteins without cleaving peptide bonds, for example, by deamidating amide groups of amino acid residues in proteins, including converting glutamine residues in proteins to glutamic acid and / or converting asparagine residues in proteins to aspartic acid.

[0023] Although protein solubility may be increased to some extent by enzymatic treatment alone, further formulation approaches are required to provide solutions that are stable against protein precipitation at pH 7 or below for extended periods of time, e.g., beyond storage conditions typical for consumer beverage and beverage additive products. Thus, the solutions described herein include stabilizers that further promote the stability of the protein solution and allow for the preparation of solutions having a pH of about 3.5 to about 7 that are stable against protein precipitation for extended periods of time, e.g., under refrigerated conditions, e.g., storage at 4°C, for 7 days, 14 days, 21 days, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, and 12 months, e.g., 4 months or 8 months. Unlike previously described formulations, the solutions described herein require only relatively small amounts of stabilizers, such that the physicochemical properties of the solution are not compromised and no unacceptable effects to the consumer, such as coagulation, stratification, precipitation, or high viscosity, are produced with the use of the stabilizers described herein.

[0024] The solutions described herein may be subjected to homogenization and may exhibit stability against protein precipitation after homogenization, as shown in the examples below. Thus, proteins formulated in the solutions described herein may remain in solution even after homogenization, even though the homogenization process may cause changes in protein-protein interactions.

[0025] As described above, according to certain embodiments, there is provided a stable protein solution comprising (i) a protein, (ii) a stabilizer, and (iii) a protein deamidase, the protein solution having a pH of about 3.5 to about 7.0 and being stable against protein precipitation. Specific aspects and embodiments are described in more detail below.

[0026] protein The proteins that can be incorporated herein are not limited, but embodiments of interest include proteins suitable for human or animal consumption, such as animal, plant, milk, and insect proteins suitable for human or animal consumption. In some embodiments, the solutions described herein include one or more proteins selected from plant proteins, milk proteins, and insect proteins.

[0027] Examples of suitable vegetable proteins include, but are not limited to, soybean, pea, lentil, chickpea, legume, hemp, rice, nut, wheat and gluten proteins. In some embodiments, the vegetable protein is selected from one or more of soybean, pea, lentil, chickpea, legume, hemp, rice, nut, wheat and gluten proteins. In some embodiments, the nut is peanut, almond, or hazelnut. In some embodiments, the protein comprises pea protein. In some embodiments, the protein comprises soybean protein. In some embodiments, the protein comprises peanut protein. In some embodiments, the protein comprises hemp protein.

[0028] Examples of suitable milk proteins include, but are not limited to, whey proteins, in some embodiments, the protein comprises whey protein.

[0029] Examples of suitable insect proteins include, but are not limited to, cricket, mole cricket, silkworm, sago worm, grasshopper, scorpion, diving beetle, German cockroach, earthworm, mealworm, and spider protein. In some embodiments, the protein comprises an insect protein selected from one or more of cricket, mole cricket, silkworm, sago worm, grasshopper, scorpion, diving beetle, German cockroach, earthworm, mealworm, and spider protein. In some embodiments, the protein comprises cricket protein.

[0030] Stabilizer As described above, the solutions described herein include a stabilizer. Examples of suitable stabilizers include, but are not limited to, hydrocolloids (gums), polysaccharides, and collagen. In some embodiments, the stabilizer includes one or more of gums, polysaccharides, and collagen. In some embodiments, the stabilizer includes one or more of xanthan gum, gellan gum, carrageenan gum, cassia gum, locust bean gum, tara gum, psyllium seed gum, gelatin, tamarind seed gum, gum arabic, alginate, propylene glycol alginate, pectin, galactomannan (guar gum), pullulan, carboxymethylcellulose (CMC), methylcellulose (MC), and any derivative or combination thereof. In certain embodiments, the stabilizer is selected from xanthan gum, gellan gum, carrageenan gum, tara gum, pectin, alginate, and CMC. In some embodiments, the stabilizer includes gellan gum. In some embodiments, the stabilizer includes carrageenan gum. In some embodiments, the stabilizer includes pectin gum. In some embodiments, the stabilizer comprises xanthan gum. As shown in the examples below, different stabilizers may be more effective at different pH ranges or values. Thus, the selection of stabilizer may be guided in some respects by the pH of the final product.

[0031] Protein deamidase As described above, the solutions described herein include a protein deamidase. As used herein, a "protein deamidase" is an enzyme that deamidates an amide group of an amino acid residue of a protein. In some embodiments, the protein deamidase deamidates an amide group of an asparagine and / or glutamine residue of a protein. In some embodiments, the protein deamidase deamidates an amide group of a glutamine residue of a protein. In some embodiments, the protein deamidase deamidates an amide group of an asparagine residue of a protein. Examples of suitable protein deamidases include those described in U.S. Pat. No. 6,756,221, U.S. Pat. No. 6,251,651, U.S. Pat. No. 7,462,477, and U.S. Pat. No. 8,735,131, which are incorporated by reference in their entireties, particularly with respect to the protein deamidases disclosed therein.

[0032] In some embodiments, the protein deamidase is produced by a bacterium selected from Chryseobacterium, Flavobacterium, Enpedobacter, Sphingobacterium, Aureobacterium, Myroides, Cytophagales, Actinomycetes, and Flavobacteriaceae, or by a Penicillium microorganism. In some embodiments, the protein deamidase is produced by a bacterium from the Chryseobacterium family. In some embodiments, the protein deamidase is produced by a bacterium from the Flavobacterium family. In some embodiments, the protein deamidase is produced by bacteria from the genus Enpedobacter. In some embodiments, the protein deamidase is produced by bacteria from the genus Sphingobacterium. In some embodiments, the protein deamidase is produced by bacteria from the genus Aureobacterium. In some embodiments, the protein deamidase is produced by bacteria from the genus Myroides. In some embodiments, the protein deamidase is produced by bacteria from the genus Cytophagales. In some embodiments, the protein deamidase is produced by bacteria from the genus Actinomycetes. In some embodiments, the protein deamidase is produced by bacteria from the family Flavobacteriaceae.

[0033] In some embodiments, the protein deamidase is the protein glutaminase deamidase "Protein Glutaminase Amano 500 (PGA500)" commercially available from Amano Enzyme.

[0034] In some embodiments, the protein deamidase has or comprises the amino acid sequence of SEQ ID NO: 1 (which is a protein glutaminase deamidase), or a sequence which has at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, or at least 99% identity thereto and has protein deamidase activity. The degree of protein deamidase activity is not particularly limited as long as it can exhibit the function of protein deamidase, but is preferably equal to or greater than that of an enzyme having the amino acid sequence of SEQ ID NO: 1. In some embodiments, the protein deamidase comprises a mutant amino acid sequence of SEQ ID NO: 1 having one or more substitutions or deletions at amino acid residues 35, 38 to 43, 45, 46, 49, 79 to 84, 103 to 106, 117, 142, 143, 146, 166, or 185 of SEQ ID NO: 1. In some embodiments, the protein deamidase comprises a mutant amino acid sequence of SEQ ID NO:1 that is at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, or at least 99% identical to SEQ ID NO:1 and has one or more substitutions or deletions at amino acid residues 35, 38-43, 45, 46, 49, 79-84, 103-106, 117, 142, 143, 146, 166, or 185 of SEQ ID NO:1, and has protein deamidase activity. In some embodiments, the protein deamidase has or comprises a mutant amino acid sequence of SEQ ID NO: 1 having one or more substitutions or deletions at amino acid residues 39, 40, 41, 43, 79-82, 142, 143, 146, 166 or 185 of SEQ ID NO: 1, such as one or more substitutions or deletions at amino acid residues 35, 38, 40-43, 45, 46, 49, 80-84, 103-106 or 117 of SEQ ID NO: 1, as described in U.S. Patent No. 8,735,131. In some embodiments, the protein deamidase has or comprises a mutant amino acid sequence of SEQ ID NO: 1 having one or more substitutions or deletions at amino acid residues 82 or 84 of SEQ ID NO: 1, as described in U.S. Patent No. 8,735,131.In some embodiments, the protein deamidase has or comprises a mutated amino acid sequence of SEQ ID NO:1, e.g., a substitution at amino acid residue 82 of SEQ ID NO:1, e.g., a serine substitution at amino acid residue 82 of SEQ ID NO:1, and / or a substitution at amino acid residue 84 of SEQ ID NO:1, e.g., an aspartic acid substitution at amino acid residue 84 of SEQ ID NO:1, as described in U.S. Pat. No. 8,735,131.

[0035] Stable Protein Solutions As noted above, in some embodiments, the stable protein solutions described herein comprise: (i) about 0.1% to about 30% w / v protein by volume of the solution; (ii) about 0.001% to about 5%, e.g., about 0.001% to about 1% w / v of a stabilizer, based on the volume of the solution; and (iii) about 0.5 U to about 50 U of protein deamidase activity, or about 0.1% to about 10%, for example, about 1% to about 10% w / w protein deamidase based on the weight of the protein in the solution, wherein the protein deamidase activity can be determined according to the assay of Example 16 below.

[0036] Thus, in some embodiments, the solution comprises about 0.1% to about 30% w / v protein, or about 0.5 to about 30% w / w, or about 5 to about 25% w / w, or about 10 to about 20% w / w protein, based on the volume of the solution (e.g., the final volume of the solution). In some embodiments, the solution comprises about 1% to about 15% w / v protein, based on the volume of the solution. In some embodiments, the solution comprises about 5% to about 15% w / v protein, based on the volume of the solution. In some embodiments, the solution comprises about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 20%, about 25%, or about 30% w / v protein by volume of the solution, for example 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 20%, 25%, or 30% w / v protein by volume of the solution.

[0037] In some embodiments, the solution comprises about 0.001% to about 5% w / v of stabilizer by volume of the solution, e.g., about 0.001% to about 1.5%, about 0.001% to about 2%, about 0.001% to about 3%, and about 0.001% to about 4% w / v of stabilizer by volume of the solution. In some embodiments, the solution comprises about 0.001% to about 1% w / v of stabilizer by volume of the solution, e.g., about 0.01% to about 1%, about 0.01% to about 0.5%, and about 0.02% to about 0.5% w / v of stabilizer by volume of the solution. In some embodiments, the solution comprises about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09%, about 0.1%, about 0.2%, about 0.3%, about 0.4%, about 0.5% w / v of a stabilizer based on the volume of the solution, such as 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1%, 0.15%, 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w / v of a stabilizer. In some embodiments, the solution comprises about 0.01%, about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09%, about 0.1%, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1.0%, about 1.5%, about 2%, about 3%, about 4% or contains about 5% w / v stabilizer, e.g., 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1%, 0.15%, 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%, 1.5%, 2%, 3%, 4%, and 5% w / v stabilizer. In some embodiments, the relatively small amount of stabilizer used results in a solution having a consumer-acceptable viscosity for beverages and beverage additives, e.g., a viscosity of about 10 to about 250 mPa·s.

[0038] In some embodiments, the solution comprises about 0.1% w / w to about 10% w / w of protein deamidase based on the weight of the protein in the solution, for example, about 0.1% w / w to about 1.0% w / w, about 0.5% w / w to about 1.0% w / w, about 0.1% w / w, about 0.2% w / w, about 0.3% w / w, about 0.4% w / w, about 0.5% w / w, or about 0.6% w / w, about 0.7% w / w, about 0.8% w / w, or about 0.9% w / w of protein deamidase based on the weight of the protein in the solution. In some embodiments, the solution comprises about 1% w / w to about 10% w / w of protein deamidase based on the weight of the protein in the solution. In some embodiments, the solution comprises about 1% w / w to about 5% w / w of protein deamidase based on the weight of the protein in the solution, for example, about 1% w / w, about 2% w / w, about 3% w / w, about 4% w / w, or about 5% w / w (including 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, or 10%) of protein deamidase based on the weight of the protein in the solution.

[0039] In some embodiments, the solution contains about 0.5 U to about 50 U of protein deamidase activity, for example, about 0.5 U to about 5.0 U, about 2.5 U to about 5.0 U, about 0.5 U, about 1.0 U, about 2.0 U, about 2.5 U, about 3.0 U, about 4.0 U, or about 5.0 U of protein deamidase activity. In some embodiments, the solution contains about 5 U to about 50 U of protein deamidase activity. In some embodiments, the solution contains about 5 U to about 25 U of protein deamidase activity, for example, about 5 U, about 10 U, about 15 U, about 20 U, or about 25 U (including 5 U, 10 U, 15 U, 20 U, 25 U, 30 U, 35 U, 40 U, ​​45 U, or 50 U) of protein deamidase activity. Protein deamidase activity may be determined as described in Example 16 below.

[0040] In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) has a pH of about 3.5 to about 7, inclusive, for example, about 3.5 to about 5.5, inclusive. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) has a pH of about 4.0 to about 5.0, inclusive. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) has a pH of about 4.0 to about 7.0, inclusive, for example, about 3.5, about 4.0, about 4.5, about 5.0, about 5.5, about 6.0, about 6.5, or about 7.0, inclusive.

[0041] In some embodiments, the viscosity of the solution (or a beverage or beverage additive comprising the solution described herein) is from about 10 to about 250 mPa·s, inclusive. In some embodiments, the viscosity of the solution (or beverage or beverage additive comprising the solution described herein) is about 10, about 20, about 30, about 40, about 50, about 60, about 70, about 80, about 90, about 100, about 110, about 120, about 130, about 140, about 150, about 160, about 170, about 180, about 190, about 200, about 210, about 220, about 230, about 240, or about 250 mPa·s (including 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, or 250 mPa·s). Viscosity can be measured using an AMETEK BROOKFIELD viscometer using spindle S61 at room temperature (~20°C).

[0042] In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for a period selected from 7 days, 14 days, 21 days, 1 month, 2 months, and 6 months. In some embodiments, the solution is stable to visible protein precipitation after storage at 4° C. for a period selected from 7 days, 14 days, 21 days, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, and 12 months, for example, 4 months or 8 months. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for 7 days. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for 14 days. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for 21 days. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for 1 month. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for 2 months. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for 4 months. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for 6 months. In some embodiments, the solution (or beverage or beverage additive comprising the solution described herein) is stable to visible protein precipitation after storage at 4° C. for 8 months.As shown above and in the Examples below, stability against precipitation can also be assessed by measuring absorbance at 280 nm, with an increase in absorbance correlating with protein solubilization, i.e., reduced or absent precipitation.

[0043] Beverages or beverage additives The protein solution described herein may be formulated as a beverage or beverage additive for human or animal consumption, or may be used to prepare a beverage or beverage additive for human or animal consumption. Examples of beverages or beverage additives include, but are not limited to, nutritional drinks, sports drinks, functional protein drinks, dairy drinks, dairy smoothies, fruit drinks, fruit smoothies, coffee drinks, tea drinks, vegetable milk, dairy creamers, and non-dairy creamers. In some embodiments, the beverage or beverage additive is selected from nutritional drinks, sports drinks, functional protein drinks, dairy drinks, dairy smoothies, fruit drinks, fruit smoothies, coffee drinks, tea drinks, vegetable milk, dairy creamers, and non-dairy creamers. The beverage or beverage additive may further include one or more fruit juices, vitamins, and flavoring agents.

[0044] As mentioned above, in some embodiments, the beverage or beverage additive comprises one or more acidic juices, for example, one or more fruit or vegetable juices, including mixtures of fruit and vegetable juices, including acidic fruit juices and / or acidic vegetable juices. Examples of such juices include apple juice, cherry juice, cranberry juice, grape juice, pineapple juice, pomegranate juice, grapefruit juice, guava juice, honeydew juice, lime juice, lemon juice, blackberry juice, orange juice, pineapple juice, raspberry juice, banana puree, apricot juice, peach juice, acai puree, acai juice, kiwi fruit juice, sugar cane juice, strawberry juice, watermelon juice, passion fruit juice, celery juice, carrot juice, potato juice, beet juice, parsley juice, tomato juice, watercress juice and turnip juice. As noted above, the present disclosure of protein solutions stable to precipitation at acidic pH allows the protein solutions to be formulated in or with fruit and / or vegetable juices to provide protein-containing fruit and / or vegetable juice-based, or fruit and / or vegetable, or fruit and / or vegetable juice-flavored beverages or beverage additives.

[0045] Preparation method Also described herein are methods for producing stable protein solutions as described herein, as well as methods for producing beverages and beverage additives. The methods may include (a) adding a protein deamidase to a solution containing a protein and a stabilizer to obtain a mixture, (b) incubating the mixture, and (c) acidifying the mixture to obtain a solution having a pH of about 3.5 to about 7.0. In some embodiments, the solution is prepared by mixing (i) a solution containing a protein and (ii) a solution containing a stabilizer. The methods may include providing a mixture containing a protein and a stabilizer, adding a protein deamidase to the mixture, and incubating the mixture. In some embodiments, the incubation is performed until the enzymatic reaction reaches a desired level of completion, which is optionally determined by the concentration of free ammonium ions in the solution. The methods may generally include mixing a solution containing a protein with a solution containing a stabilizer to obtain a mixture containing a protein and a stabilizer, adding a protein deamidase to the mixture, and incubating the mixture. The mixing and addition may be performed in any order. In some embodiments, mixing is completed before the enzyme is added.

[0046] The method may also include adjusting the pH of the solution to a pH of about 3.5 to about 7.0, for example, by acidifying the solution to a pH of about 3.5 to about 7.0. In some embodiments, acidifying the solution includes adding an acidic juice or juice concentrate, such as an acidic fruit juice or acidic fruit juice concentrate, and / or an acidic vegetable juice or acidic vegetable juice concentrate. In some embodiments, the solution is acidified with two or more acidifying agents, such as, for example, an acidic additive and an acidic juice or juice concentrate. In some embodiments, an acidifying agent is added for other purposes, such as flavoring the solution or enhancing the nutritional or functional food content, and the acidic pH results from the amount of acidifying agent added for that purpose.

[0047] The incubation conditions can be any incubation conditions suitable for the particular protein deamidating enzyme used, such as any temperature and pH at which the enzyme is active, and any time necessary to achieve the desired level of deamidation. In some embodiments, the progress of the deamidation reaction is monitored, such as by measuring the concentration of free ammonium ions in the solution. For example, the reaction may be considered complete when the concentration of free ammonium ions in the solution reaches a particular level. For solutions having protein amounts described herein, the concentration of free ammonium ions in the solution may be about 0.002% to about 0.07% w / v based on the volume of the solution, such as 0.002% to 0.07% w / v (about 0.002%, about 0.003%, about 0.004%, about 0.005%, about 0.006%, about 0.007%, about 0.008%, about 0.009%, about 0.01%, about 0.02%, about 0.03%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.007%, about 0.008%, about 0.009%, about 0.01%, about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09 ...2%, about 0.03%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0. %, about 0.03%, about 0.04%, about 0.05%, about 0.06%, or about 0.07% w / v, or including 0.002%, 0.003%, 0.004%, 0.005%, 0.006%, 0.007%, 0.008%, 0.009%, 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, or 0.07% w / v), the reaction can be considered complete. Incubation conditions can include stirring. The stirring can be slow (e.g., about 150 to about 250 rpm) or fast (e.g., about 3,000 to about 5,000 rpm). In some embodiments, the stirring is performed using a shaking table at a stirring speed of about 150 to about 250 rpm. In some embodiments, the stirring is performed using a shaking table at a rate ranging from about 3,000 to about 5,000 rpm.

[0048] The incubation step may be carried out at a temperature of about 30° C. to about 70° C., for about 0.5 hours to about 48 hours, and at a pH of about 3.0 to about 8.0. Typically, the incubation is carried out at a temperature of about 40° C. to about 60° C., for about 3 hours to about 24 hours, and at a pH of about 5.0 to about 8.0. In some embodiments, the incubation is carried out at a temperature of about 30° C., about 35° C., about 40° C., about 45° C., about 50° C., about 55° C., about 60° C., about 65° C., or about 70° C. In some embodiments, the incubation is for about 0.5 hours, about 1 hour, about 2 hours, about 3 hours, about 4 hours, about 5 hours, about 6 hours, about 7 hours, about 8 hours, about 9 hours, about 10 hours, about 11 hours, about 12 hours, about 13 hours, about 14 hours, about 15 hours, about 16 hours, about 17 hours, about 18 hours, about 19 hours, about 20 hours, about 21 hours, about 22 hours, about 23 hours, about 24 hours, about 48 hours. In some embodiments, the incubation is at a pH of about 3, about 3.5, about 4, about 4.5, about 5.0, about 5.5, about 6.0, about 6.5, about 7.0, about 7.5, or about 8.0.

[0049] In some embodiments, the protein deamidase is Protein Glutaminase Amano 500 (PGA500) and incubation is performed at 50° C. for 3 hours at a pH of about 5.0 to about 8.0. In some embodiments, the protein deamidase has or comprises the amino acid sequence of SEQ ID NO: 1 and incubation is performed at 50° C. for 3 hours at a pH of about 5.0 to about 8.0. In some embodiments, the protein deamidase is a variant of SEQ ID NO: 1 described herein and incubation is performed at 50° C. for 3 hours at a pH of about 5.0 to about 8.0.

[0050] The solution may be subjected to one or more further processing steps, such as one or more of the addition of one or more flavor or nutritional ingredients, heat treatment, homogenization, filtration, pasteurization, and sterilization.

[0051] In some embodiments, the method further comprises subjecting the solution to heat treatment, e.g., heat treatment at about 75° C. to about 95° C. for about 5 minutes to about 20 minutes. In some embodiments, the heat treatment is performed at about 75° C., about 80° C., about 85° C., about 90° C., or about 95° C. for about 5 minutes, 10 minutes, 15 minutes, or about 20 minutes. In some embodiments, the heat treatment is performed at about 85° C. for about 10 minutes.

[0052] In some embodiments, the process further comprises subjecting the solution to homogenization. In some embodiments, the homogenization is performed at a pressure of about 2,000 psi to about 20,000 psi, such as about 2,000 psi to about 2,500 psi. In some embodiments, the homogenization is performed at a pressure of about 2,000 psi, about 5,000 psi, about 10,000 psi, about 15,000 psi, or about 20,000 psi. In some embodiments, the homogenization is performed at a pressure of about 2,000 psi, about 2,500 psi, about 3,000 psi, about 3,500 psi, about 4,000 psi, about 4,500 psi, or about 5,000 psi.

[0053] In some embodiments, the process further comprises subjecting the solution to sterilization. In some embodiments, the sterilization is performed using high temperature short time (HTST) sterilization, ultra high temperature (UHT) sterilization, or low temperature long time (LTLT) sterilization. In some embodiments, the sterilization is performed using high temperature short time (HTST) sterilization. In some embodiments, the sterilization is performed using high temperature short time (HTST) sterilization at about 90° C. to about 110° C. for about 5 seconds to about 30 seconds. In some embodiments, the sterilization is performed using high temperature short time (HTST) sterilization at about 100° C. for about 10 seconds to about 20 seconds. In some embodiments, the sterilization is performed using ultra high temperature (UHT) sterilization. In some embodiments, the sterilization is performed using ultra high temperature (UHT) sterilization at about 110° C. to about 130° C. for about 1 second to about 10 seconds. In some embodiments, the sterilization is performed using ultra high temperature (UHT) sterilization at about 120° C. for about 1 second to about 3 seconds. In some embodiments, the sterilization is performed using low temperature long time (LTLT) sterilization. In some embodiments, sterilization is performed using low temperature, long time (LTLT) sterilization at about 65° C. to about 95° C. for about 5 minutes to about 30 minutes. In some embodiments, sterilization is performed using low temperature, long time (LTLT) sterilization at about 75° C. to about 85° C. for about 10 minutes to about 20 minutes.

[0054] In some embodiments, the process further comprises subjecting the solution to sterilization, hi some embodiments, the sterilization is performed using high pressure (high specific gravity) sterilization.

[0055] The method of producing the beverage or beverage additive described herein may include adding the stable protein solution described herein to a beverage or beverage additive composition or preparing the solution described herein as a beverage or beverage additive.For example, the stable protein solution described herein can be added to a pre-prepared nutritional beverage, sports beverage, functional protein beverage, dairy beverage, dairy smoothie, fruit beverage, fruit smoothie, coffee beverage, tea beverage, vegetable milk, dairy creamer or non-dairy creamer in an amount that provides a desired amount of protein in the beverage or beverage additive.Alternatively, the stable protein solution described herein can be prepared as a nutritional beverage, sports beverage, functional protein beverage, dairy beverage, dairy smoothie, fruit beverage, fruit smoothie, coffee beverage, tea beverage, vegetable milk, dairy creamer or non-dairy creamer, for example, with other components of such beverage and beverage additive, and a desired amount of protein.

[0056] In some embodiments, the final solution, beverage, or beverage additive has a protein content of up to about 30% w / w, including about 30% w / w, based on the weight of the protein in solution. In some embodiments, the final solution, beverage, or beverage additive has a protein content of about 0.5 to about 30% w / w, including 0.5 to 30% w / w, or about 5 to about 25% w / w, or about 10 to about 20% w / w, based on the weight of the protein in solution. In some embodiments, the final solution, beverage, or beverage additive has a protein content of about 0.5%, about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19%, about 20%, about 21%, about 22%, about 23%, about 24%, about 25%, about 26%, about 27%, about 28%, about 29%, or about 30% w / w, based on the weight of protein in the solution.

[0057] In any embodiment, the beverage or beverage additive may further comprise one or more ingredients normally present in beverages or beverage additives, including one or more of fruit or vegetable juices, vitamins, dietary supplements, flavorings, colorings, and preservatives. In some embodiments, the beverage or beverage additive comprises one or more acidic juices or one or more fruit and vegetable juices, including one or more acidic fruit juices, including one or more selected from apple juice, cherry juice, cranberry juice, grape juice, pineapple juice, pomegranate juice, grapefruit juice, guava juice, honeydew juice, lime juice, lemon juice, blackberry juice, orange juice, pineapple juice, raspberry juice, banana puree, apricot juice, peach juice, acai puree, acai juice, kiwi fruit juice, sugar cane juice, strawberry juice, watermelon juice, passion fruit juice, celery juice, carrot juice, potato juice, beet juice, parsley juice, tomato juice, watercress juice, and turnip juice.

[0058] The following specific examples are included as illustrations of the compositions and methods described herein. These examples are not intended to limit the scope of the disclosure in any way. Other aspects of the disclosure will be apparent to those of skill in the art to which this disclosure pertains. EXAMPLES

[0059] Example 1: Pea protein solutions (formulations 1-4) As shown in the table below, pea protein solutions were prepared using pea protein isolate in powder form (NOW Foods) as the protein, with and without gellan gum (Ticagel® Gellan HS NGMO, high acyl gellan gum from TIC Gums) as a stabilizer, and with and without PGA500 (Amano Enzyme Inc.) as a protein deamidating enzyme.

[0060] For example, a 10% (w / v) aqueous solution of pea protein was prepared and mixed with a 0.2% (w / v) aqueous solution of gellan gum to obtain an aqueous solution containing 3% (w / v) pea protein and 0.03-0.05% (w / v) gellan gum. For the PGA500-containing solution, the enzyme was added in an amount of 2% (w / w) of protein and incubated at 50 °C for 3 h. For the PGA500-free formulation, the solution was heated to 50 °C without incubation. After acidification with citric acid to pH 4.0-4.5, it was heat-treated at 85 °C for 10 min. Other formulations were made by a similar process.

[0061] The resulting solutions were stored at 4°C in a laboratory VWR refrigerator and evaluated after 24 and 72 hours by (i) visual inspection, (2) measuring the soluble protein content of the supernatant at 280 nm absorbance, (3) measuring the viscosity using a viscometer (AMETEK BROOKFIELD), and (4) measuring the pH. The results are reported in the table below. [Table 1]

[0062] The results show that a formulation according to the present disclosure (containing PGA500 and gum) (Formulation 2) was stable to protein precipitation at a pH of about 4.5, as indicated by the appearance of dispersion versus separation and higher absorbance (reflecting increased protein solubility).

[0063] Example 2: Soy Protein Solutions (Formulations 5-12) As shown in the table below, soy protein solutions were prepared using soy protein isolate in powder form (NOW Foods) as the protein, with and without gellan gum (Ticagel® Gellan HS NGMO from TIC Gums) as a stabilizer, and with and without PGA500 (Amano Enzyme Inc.) as a protein deamidating enzyme.

[0064] For example, a 10% (w / v) aqueous solution of soy protein was prepared and mixed with a 0.2% (w / v) aqueous solution of gellan gum to obtain an aqueous solution containing 3% (w / v) soy protein and 0.10% (w / v) gellan gum. For the PGA500-containing formulation, the enzyme was added in an amount of 2% (w / w) of the protein and incubated at 50°C for 3 hours. For the PGA500-free formulation, the solution was heated to 50°C without incubation. After acidification to pH 4.0-4.6 with citric acid, it was heat-treated at 85°C for 10 minutes. The other formulations were made by a similar process.

[0065] The resulting solutions were stored at 4° C. in a VWR laboratory refrigerator and evaluated as described above in Example 1. The results are reported in the table below. [Table 2]

[0066] The results show that formulations according to the present disclosure (containing PGA500 and gum) (Formulations 6 and 10) were stable to protein precipitation at acidic pH (about 4.0-4.5) as indicated by the appearance of dispersion versus separation and higher absorbance.

[0067] Example 3: Peanut Protein Solutions (Formulations 13-16) As shown in the table below, peanut protein solutions were prepared using peanut protein powder (Tru-Nut Company) as the protein, with and without gellan gum (Ticagel® Gellan HS NGMO from TIC Gums) as a stabilizer, and with and without PGA500 (Amano Enzyme Inc.) as a protein deamidating enzyme.

[0068] For example, a 10% (w / v) aqueous solution of peanut protein was prepared and mixed with a 0.2% (w / v) aqueous solution of gellan gum to obtain an aqueous solution containing 3% (w / v) peanut protein and 0.02% (w / v) gellan gum. For the PGA500-containing formulation, the enzyme was added in an amount of 2% (w / w) of protein and incubated at 50°C for 3 hours. For the PGA500-free formulation, the solution was heated to 50°C without incubation. After acidification to pH 4.0-4.5 with citric acid, it was heat-treated at 85°C for 10 minutes. Other formulations were made by similar processes.

[0069] The resulting solutions were stored at 4° C. in a VWR laboratory refrigerator and evaluated as described above in Example 1. The results are reported in the table below. [Table 3]

[0070] The results show that the formulation according to the present disclosure (containing PGA500 and gum) (Formulation 14) was more stable to protein precipitation at acidic pH (about 4.0) as indicated by higher absorbance (reflecting increased protein solubility) compared to the other formulations. The slight precipitation observed may be due to the nature of peanut protein and the fact that the processing conditions were not optimized for peanut protein.

[0071] Example 4: Cricket protein solutions (formulations 17-24) As shown in the table below, cricket protein solutions were prepared using cricket powder (LITHIC) containing 68% (w / w) cricket protein with and without gellan gum (Ticagel® Gellan HS NGMO from TIC Gums) as a stabilizer, and with and without PGA500 (Amano Enzyme Inc.) as a protein deamidating enzyme.

[0072] For example, a 10% (w / v) aqueous solution of cricket powder was prepared and mixed with a 0.2% (w / v) aqueous solution of gellan gum to obtain an aqueous solution containing 3% (w / v) cricket powder and .03% (w / v) gellan gum. For the PGA500-containing solution, enzyme was added in an amount of 2% (w / w) of protein and incubated at 50°C for 3 hours. For the PGA500-free formulation, the solution was heated to 50°C without incubation. After acidification with citric acid to pH 4.0-4.5, it was heat-treated at 85°C for 10 minutes. Other formulations were made by similar processes.

[0073] The resulting solutions were stored at 4° C. in a VWR laboratory refrigerator and evaluated as described above in Example 1. The results are reported in the table below. [Table 4]

[0074] The results show that formulations according to the present disclosure (containing PGA500 and gum) (Formulations 18 and 22) were more stable to protein precipitation at acidic pH (about 4.0 to about 4.5) as indicated by higher absorbance values ​​(reflecting increased protein solubility) than the other formulations. Because formulations 17-20 were prepared near pH 4.5 (with some measurement error) while formulations 21-24 were near pH 4.0, the lower pH of formulation 22 (pH 4.0) compared to formulation 18 (pH 4.5) indicates that the lower pH resulted in less protein in suspension, resulting in the lower absorbance and viscosity observed for formulation 22.

[0075] Example 5: Hemp Protein Solutions (Formulations 25-28) As shown in the table below, hemp protein solutions were prepared using hemp protein powder (Nutiva) as the protein, with and without carrageenan gum (Ticaloid® 750 from TIC Gums) as a stabilizer, and with and without PGA500 (Amano Enzyme Co., Ltd.) as a protein deamidating enzyme.

[0076] For example, a 10% (w / v) aqueous solution of hemp protein was prepared and mixed with a 1.0% (w / v) aqueous solution of carrageenan gum to obtain an aqueous solution containing 3% (w / v) hemp protein and 0.5% (w / v) carrageenan gum. For the PGA500-containing solution, enzyme was added in an amount of 2% (w / w) of protein and incubated at 50°C for 3 hours. For the PGA500-free formulation, the solution was heated to 50°C without incubation. After acidification to pH 4.0-4.5 with citric acid, it was heat-treated at 85°C for 10 minutes. Other formulations were made by similar processes.

[0077] The resulting solutions were stored at 4° C. in a VWR laboratory refrigerator and evaluated as described above in Example 1. The results are reported in the table below. [Table 5]

[0078] The results show that a formulation according to the present disclosure (containing PGA500 and gum) (Formulation 26) was stable to protein precipitation at acidic pH (about 4.5) as indicated by the appearance of dispersion versus separation and higher absorbance (reflecting increased protein solubility).

[0079] Example 6: Pea protein solutions at pH 3.5-7.0 (formulations 29-37) Pea protein solutions were prepared using pea protein isolate in powder form (NOW Foods) as the protein, with and without gums as stabilizers, and with and without PGA500 (Amano Enzyme Co., Ltd.) as the protein deamidating enzyme, as shown in the table below. The following gums from TIC Gums were used: gellan (Ticagel® Gellan HS NGMO), pectin (Pre-Hydrated® Pectin 1694 Powder), carboxymethylcellulose (CMC, Pre-Hydrated® Ticalose® CMC 2500 Powder), alginate (TICA-algin® HG-400 Powder), and tara gum (TIC Pretested® Tara Gum 100).

[0080] For example, a 10% (w / v) aqueous solution of pea protein was prepared and mixed with an aqueous gum solution to obtain an aqueous solution containing 3% (w / v) pea protein and gum at the concentrations (% w / v) shown in the table below. For the PGA500-containing formulations (formulations "A" in the table below), the enzyme was added in an amount of 2% (w / w) of protein and incubated at 50°C for 3 hours. For the formulations not containing PGA500 (formulations "B" in the table below), the solution was heated to 50°C without incubation. The solution was acidified with citric acid to pH 3.5-7 (as indicated in the table) and then heat treated at 85°C for 10 minutes. The other formulations were made by a similar process.

[0081] The resulting solutions were stored at 4°C in a laboratory VWR refrigerator and evaluated initially after 24 hours and periodically thereafter for up to two months by (i) visual inspection, (ii) measurement of the soluble protein content of the supernatant at absorbance at 280 nm, and (iii) pH measurement. The results are reported in the table below and shown in Figure 1. [Table 6] [Table 7]

[0082] The results show that formulations according to the present disclosure (containing PGA500 and gum) (Formulations 29A-37A) were stable to protein precipitation at pHs from about 3.5 to about 7, as indicated by the appearance of dispersion versus separation and higher absorbance (reflecting increased protein solubility), whereas formulations without protein deamidase were less stable at pHs below about 4.0.

[0083] Example 7: Soy Protein Solutions at pH 3.5-7.0 (Formulations 38-45) Soy protein isolate in powder form (NOW Foods) was used as the protein to prepare and evaluate soy protein solutions as described in Example 6. The results are reported in the table below and shown in FIG. [Table 8] [Table 9]

[0084] The results show that formulations according to the present disclosure (containing PGA500 and gum) (Formulations 38A-45A) were stable to protein precipitation in the pH range of about 3.5 to about 7, as indicated by the appearance of dispersion versus separation and higher absorbance (reflecting increased protein solubility). In contrast, other formulations (containing gum but not PGA500) were not stable to protein precipitation below pH 5.2 (see results reported for pH 4.4-3.5).

[0085] Example 8: Hemp Protein Solutions at pH 3.5-6.5 (Formulations 46-52) Hemp protein solutions were prepared and evaluated using hemp protein powder (Nutiva) as the protein as described in Example 6. The results are reported in the table below and shown in Figure 3. [Table 10] [Table 11]

[0086] The results show that formulations according to the present disclosure (containing PGA500 and gum) (Formulations 46A-52A) were more stable to protein precipitation in the pH range of about 3.5 to about 7, as indicated by a dispersed appearance and higher absorbance (reflecting increased protein solubility).

[0087] Example 9: Peanut Protein Solutions at pH 3.5-7.0 (Formulations 53-59) Peanut protein solutions were prepared and evaluated as described in Example 6 using peanut protein powder (Tru-Nut Company) and xanthan gum (Pre-Hydrated® Ticaxan® Xanthan EC NGMO from TIC Gums) as the protein. The results are reported in the table below and shown in FIG. 4. [Table 12] [Table 13]

[0088] The results show that formulations according to the present disclosure (containing PGA500 and gum) (Formulations 53A-59A) were stable to protein precipitation in the pH range of about 3.5 to about 7, as indicated by the dispersed appearance and higher absorbance (reflecting increased protein solubility), while the other formulations were less stable, especially at more acidic pH values.

[0089] Example 10: Cricket protein solutions with pH 3.5-7.0 (formulations 60-67) Cricket powder containing 68% (w / w) cricket protein (LITHIC) was used to prepare and evaluate cricket protein solutions in a similar manner as described in Example 6. The results are reported in the table below and shown in Figure 5. [Table 14] [Table 15]

[0090] The results show that formulations according to the present disclosure (containing PGA500 and gum) (formulations 60A-67A) were stable against protein precipitation in the pH range of about 3.5 to about 7, as indicated by the dispersed appearance and higher absorbance (reflecting increased protein solubility). Sedimentation was observed in formulation 62A, which may be due to the fact that the specific amount of gellan gum used at pH 5.1 was not sufficient to completely prevent protein precipitation. Most of the other formulations were less stable, especially at more acidic pH values ​​(e.g., below about 4.5). Without wishing to be bound by theory, it is possible that the cricket protein used was not pure cricket protein but contained impurities such as non-protein impurities.

[0091] Example 11: Homogenized Pea Protein Solutions (Formulations 68-71) As shown in the table below, pea protein solutions were prepared using pea protein isolate in powder form (NOW Foods) as the protein, with and without gums as stabilizers (gellan: Ticagel® Gellan HS NGMO; pectin: Pre-Hydrated® Pectin 1694 Powder, both from TIC Gums), and with and without PGA500 (Amano Enzyme Inc.) as the protein deamidating enzyme.

[0092] For example, solutions were prepared by hydrating 0.075% (w / w) gellan gum and 0.45% (w / w) pectin in water. Pea protein was added to obtain pea protein solutions with different amounts of pea protein as shown in the table below. For PGA500-containing formulations, enzyme was added in an amount of 0.67%-1.8% (w / w) of protein and incubated at 50°C for 3 hours. For PGA500-free formulations, the solution was heated to 50°C without incubation. For acidification, 1M (molar) citric acid was used to bring to a specific pH. The acidified solution was homogenized at 2,000-2,500 psi and then heat treated at 85°C for 10 minutes. Other formulations were made by a similar process.

[0093] Protein deamidase activity was measured according to Example 16.

[0094] The resulting solutions were stored at 4° C. in a VWR laboratory refrigerator and evaluated as described above in Example 6. The results are reported in the table below and shown in FIG. [Table 16]

[0095] The results show that formulations according to the present disclosure (containing PGA 500 and gum) (Formulations 68B-71B) were stable to protein precipitation at acidic pH (about 4.0 to about 4.5) as indicated by the dispersed appearance and higher absorbance (reflecting increased protein solubility). These results indicate that the improved stability achieved with the formulations disclosed herein is maintained even after homogenization.

[0096] Example 12: Homogenized Soy Protein Solutions with Juice Concentrate (Formulations 72-74) As shown in the table below, soy protein solutions were prepared using soy protein isolate in powder form (NOW Foods) as the protein, with and without gums as stabilizers (gellan: Ticagel® Gellan HS NGMO; pectin: Pre-Hydrated® Pectin 1694 Powder, both from TIC Gums), and with and without PGA500 (Amano Enzyme Inc.) as the protein deamidating enzyme.

[0097] For example, solutions were prepared by hydrating 0.06% or 0.075% (w / w) gellan gum and 0.45% (w / w) pectin in water. Soy protein isolate was added to obtain soy protein solutions with different amounts of soy protein as shown in the table below. For PGA500-containing formulations, enzymes were added in amounts of 0.67%-2.4% (w / w) of protein and incubated at 50°C for 3 hours. For PGA500-free formulations, the solutions were heated to 50°C without incubation. For acidification, berry juice concentrate (100% Juice Berry Blend concentrate with Brix value of 65, from Old Orchard) was added in a 1:2 w / w ratio. The acidified solutions were homogenized at 2,000-2,500 psi and then heat treated at 85°C for 10 minutes. Other formulations were made by a similar process. Protein deamidase activity was measured according to Example 16.

[0098] The resulting solutions were stored at 4° C. in a VWR laboratory refrigerator and evaluated as described above in Example 6. The results are reported in the table below and shown in FIG. [Table 17]

[0099] The results show that formulations according to the present disclosure (containing PGA 500 and gum) (Formulations 72B-74B) were stable to protein precipitation at acidic pH (about 4.0 to about 4.5) as indicated by the dispersed appearance and higher absorbance (reflecting increased protein solubility). These results indicate that the improved stability achieved with the formulations disclosed herein is maintained even after homogenization.

[0100] Example 13: Homogenized Peanut Protein Solutions with Juice Concentrate (Formulations 75-77) As shown in the table below, peanut protein solutions were prepared using peanut protein powder (Tru-Nut Company) as the protein, with and without gums as stabilizers (gellan: Ticagel® Gellan HS NGMO; pectin: Pre-Hydrated® Pectin 1694 Powder, both from TIC Gums), and with and without PGA500 (Amano Enzyme Inc.) as the protein deamidating enzyme.

[0101] For example, solutions were prepared by hydrating gellan gum and pectin in the amounts shown in the table below in water. Peanut protein was added to obtain peanut protein solutions with different amounts of peanut protein as shown in the table below. For the PGA500-containing formulations, the enzyme was added in an amount of 0.67%-3.6% (w / w) of protein and incubated at 50°C for 3 hours. For the PGA500-free formulations, the solutions were heated to 50°C without incubation. For acidification, berry juice concentrate (100% Juice Berry Blend concentrate with Brix value of 65, from Old Orchard) was added in a 1:2 w / w ratio. The acidified solutions were homogenized at 2,000-2,500 psi and then heat-treated at 85°C for 10 minutes. Other formulations were made by similar processes. The activity of protein deamidation enzyme was measured according to Example 16.

[0102] The resulting solutions were stored at 4° C. in a VWR laboratory refrigerator and evaluated as described above in Example 6. The results are reported in the table below and shown in FIG. [Table 18]

[0103] The results show that formulations according to the present disclosure (containing PGA 500 and gum) (Formulations 75B-77B) were stable to protein precipitation at acidic pH (about 4.0 to about 4.5) as indicated by the dispersed appearance and higher absorbance (reflecting increased protein solubility). These results indicate that the improved stability achieved with the formulations disclosed herein is maintained even after homogenization.

[0104] Example 14: Homogenized Almond Protein Solutions (Formulations 78-79) As shown in the table below, almond protein solutions were prepared using almond protein powder (Noosh Brands) as the protein, with and without gums as stabilizers (gellan: Ticagel® Gellan HS NGMO; pectin: Pre-Hydrated® Pectin 1694 Powder, both from TIC Gums), and with and without PGA500 (Amano Enzyme Inc.) as a protein deamidating enzyme.

[0105] For example, solutions were prepared by hydrating 0.06% (w / w) gellan gum or 0.45% (w / w) pectin in water. Almond protein was added to obtain an almond solution containing 3% (w / w) almond protein. For the PGA500-containing formulations, the enzyme was added in an amount of 3.3% (w / w) of protein and incubated at 50°C for 3 hours. For the PGA500-free formulations, the solution was heated to 50°C without incubation. For acidification, berry juice concentrate (100% Juice Berry Blend concentrate with Brix value 65, from Old Orchard) was added in a 1:2 w / w ratio. The acidified solution was homogenized at 2,000-2,500 psi and then heat-treated at 85°C for 10 minutes. The activity of protein deamidation enzyme was measured according to Example 16.

[0106] The resulting solutions were stored at 4° C. in a VWR laboratory refrigerator and evaluated as described above for Example 6. The results are reported in the table below. [Table 19]

[0107] The results show that formulations according to the present disclosure (containing PGA500 and gum) (Formulations 78B-79B) were stable to protein precipitation at acidic pH (about 4.0) as indicated by the dispersed appearance and higher absorbance (reflecting increased protein solubility). These results indicate that the improved stability achieved with the formulations disclosed herein is maintained even after homogenization.

[0108] The results show that at a pH of about 4.0 to about 4.2, the comparative formulations without PGA500 but with gum (Formulations 78A and 79A) show separation and lower absorbance values ​​(reduced protein solubility) in comparison to both of the PGA500 formulations with gum (Formulations 78B and 79B) which are stable as shown by higher absorbance values ​​(increased protein solubility) and no precipitation or settling. These results indicate that the stability observed with the combination of PGA500 and gum is maintained upon homogenization.

[0109] Example 15: Long-term stability study Long-term stability testing is performed as follows: The formulations described below are mixed in a certified commercial pilot plant and aseptically packaged to produce commercially pasteurized stable products and stored under refrigerated conditions (4° C.) for up to 6 months. These products will be stable to protein precipitation. [Table 20]

[0110] For example, the following process can be used to prepare a commercial disinfectant formulation. 1. Weigh out the pectin gum, gellan gum, water, and pea protein. 2. Mixing gum and water under high shear conditions. Activate the gum in the solution by heating to 3.85°C and holding. 4. Transfer the gum solution to a 100 L tray and add the protein. 5. Add the enzyme to the vat and mix thoroughly. Transfer the solution to a container and incubate at 50°C for 3 hours. 6. Weigh out juice concentrate and food coloring. 7. Return the solution to the 100 L vat and add the juice concentrate and food coloring. 8. Once adequately mixed, the mixture is sent to an Ultra High Temperature (UHT; e.g., about 120°C for about 1 second to about 3 seconds) / High Temperature Short Time (HTST; e.g., about 100°C for about 10 seconds to about 20 seconds) system for sterilization. 9. Send the pasteurized product to a homogenizer for homogenization at 2000 psi. 10. Bottle the product in a sterile environment, cap and transfer to storage boxes.

[0111] Stability studies to date indicate that the above protein deamidase formulation is stable after storage at 4° C. for 25 weeks.

[0112] Example 16: Protein deamidation enzyme activity assay The activity of protein deamidase can be measured by the following method, which is exemplified by referring to protein glutaminase deamidation activity. A similar assay can be performed for protein asparaginase deamidation activity using a substrate suitable for protein asparaginase deamidation (e.g., Z-Asn-Gly).

[0113] A test solution is prepared by adding 0.1 mL of an aqueous solution containing protein deamidase to 1 mL of 0.2 M phosphate buffer (pH 6.5) containing 30 mM Z-Gln-Gly (substrate for protein glutaminase deamidation activity assay) and incubating at 37°C for 10 minutes. The reaction is terminated by adding 1 mL of 0.4 M trichloroacetic acid (TCA) solution. A blank solution is prepared by adding 0.1 mL of an aqueous solution containing protein deamidase to a solution containing 1 mL of 0.2 M phosphate buffer (pH 6.5) containing 30 mM Z-Gln-Gly (for protein glutaminase deamidation activity assay) and 1 mL of 0.4 M trichloroacetic acid (TCA) solution and incubating at 37°C for 10 minutes. The amount of ammonia generated in the test solution by the reaction is measured using an Ammonia Test Wako (manufactured by Wako Pure Chemical Industries, Ltd.), which determines the ammonia concentration using a calibration curve of ammonia concentration versus absorbance (at 630 nm) created using an ammonia standard solution (ammonium chloride). The activity of protein deamidase can be calculated as follows (1 unit = the amount of enzyme required to produce 1 μmol of ammonia per minute): Enzyme activity (U / mL)= (Ammonia concentration in reaction solution (mg / L)) x (1 / 17.03) x (2.1 / 0.1) x (1 / 10) x Df During the ceremony, 17.03 is the molecular weight of ammonia 2.1 is the volume (mL) of the enzyme reaction system in the above protocol, 0.1 is the volume (mL) of the enzyme solution in the above protocol, 10 is the reaction time (min) in the above protocol, Df is the dilution factor of the enzyme solution.

[0114] Taken together, these examples demonstrate that for a variety of proteins from a variety of sources, stable protein solutions can be prepared as described herein, and that such protein solutions are stable to protein precipitation at acidic pH, including formulations acidified with fruit juice concentrate. The examples also demonstrate that protein solutions formulated as described herein are stable after homogenization. [Sequence table] SEQ ID NO:1 LASVIPDVATLNSLFNQIKNQSCGTSTASSPCITFRYPVDGCYARAHKMRQILMNNGYDCEKQFVYGNLKASTGTCCVAWSYHVAILVSYKNASGVTEKRIIDPSLFSSGPVTDTAWRNACVNTSCGSASVSSYANTAGNVYYRSPSNSYLYDNNLINTNCVLTKFSLLSGCSPSPAPDVSSCGF

Claims

1. 1. A stable protein solution comprising: (i) 0.1% to 30% w / v protein, based on the volume of the solution; (ii) 0.001% to 5% w / v of a stabilizer based on the volume of the solution; and (iii) a protein deamidase activity of 0.5 U to 50 U, or a protein deamidase activity of 0.1% to 10% w / w based on the weight of the protein in the solution, wherein the protein deamidase is a protein asparaginase deamidase that deamidates an amide group of an asparagine residue in a protein; A solution having a pH between 3.5 and 7.0, which is stable against protein precipitation.

2. 1. A stable protein solution comprising: (i) 0.1% to 30% w / v protein, based on the volume of the solution; (ii) 0.001% to 5% w / v of a stabilizer based on the volume of the solution; and (iii) comprising 0.5 U to 50 U of protein deamidase activity or 0.1% to 10% w / w of protein deamidase based on the weight of the protein in the solution, wherein the protein deamidase comprises the amino acid sequence of SEQ ID NO: 1 or a sequence having at least 85% identity thereto and having protein deamidase activity; A solution having a pH between 3.5 and 7.0, which is stable against protein precipitation.

3. 1. A stable protein solution comprising: (i) 0.1% to 30% w / v protein, based on the volume of the solution; (ii) 0.001% to 5% w / v of a stabilizer based on the volume of the solution; and (iii) comprising 0.5 U to 50 U of protein deamidase activity, or 0.1% to 10% w / w of protein deamidase based on the weight of protein in the solution, wherein the protein deamidase has protein deamidase activity and comprises a variant amino acid sequence of SEQ ID NO: 1 having one or more substitutions or deletions at amino acid residues 35, 38 to 43, 45, 46, 49, 79 to 84, 103 to 106, 117, 142, 143, 146, 166, or 185 of SEQ ID NO: 1, optionally wherein the variant sequence has at least 85% identity to SEQ ID NO: 1; A solution having a pH between 3.5 and 7.0, which is stable against protein precipitation.

4. The solution of any one of claims 1 to 3, wherein the protein comprises one or more selected from vegetable proteins, dairy proteins, and insect proteins.

5. 5. The solution of claim 4, wherein the protein comprises a vegetable protein selected from one or more of soy, pea, lentil, chickpea, legume, hemp, rice, nut, wheat and gluten protein.

6. 6. The solution of claim 5, wherein the nuts are peanuts, almonds, or hazelnuts.

7. 5. The solution of claim 4, wherein the protein comprises whey protein.

8. 5. The solution of claim 4, wherein the protein comprises an insect protein selected from one or more of cricket, mole cricket, silkworm, sago worm, grasshopper, scorpion, diving beetle, German cockroach, earthworm, mealworm, and spider protein.

9. The solution of any one of claims 1 to 8, wherein the stabilizing agent comprises one or more of a gum, a polysaccharide, and a collagen.

10. 10. The solution of claim 9, wherein the stabilizer comprises one or more of xanthan gum, gellan gum, carrageenan gum, cassia gum, locust bean gum, tara gum, psyllium seed gum, gelatin, tamarind seed gum, gum arabic, propylene glycol alginate, pectin, galactomannan (guar gum), pullulan, carboxymethylcellulose (CMC), methylcellulose (MC), and any derivatives or combinations thereof.

11. 2. The solution of claim 1, wherein the protein asparaginase deamidase is produced by a bacterium selected from Chryseobacterium, Flavobacterium, Empedobacter, Sphingobacterium, Aureobacterium, Myroides, Cytophagales, Actinomycetes, and Flavobacteriaceae.

12. The solution according to any one of claims 1 to 11, (i) 0.001% to 1% w / v of a stabilizer based on the volume of the solution; and (ii) A solution comprising 5 U to 50 U of protein deamidase activity, or 1% to 10% w / w of protein deamidase based on the weight of protein in the solution.

13. The solution according to any one of claims 1 to 12, having a viscosity of 10 to 250 mPa·s.

14. 14. The solution of claim 13 comprising 5% to 15% w / v protein based on the volume of the solution.

15. 14. The solution of claim 13, comprising 0.01% to 1% w / v or 0.02% to 0.5% w / v of a stabilizer based on the volume of the solution.

16. 14. The solution according to claim 13, comprising 5 U to 25 U of protein deamidation activity, or 1% w / w to 5% w / w of protein deamidating enzyme based on the weight of protein in the solution.

17. 17. The solution according to any one of claims 1 to 16, having a pH of from 4.0 to 7.0 or from 4.0 to 5.

0.

18. 18. The solution of any one of claims 1 to 17, which is stable to visible precipitation of protein after storage at 4°C for a period selected from 7 days, 14 days, 21 days, 1 month, 2 months, 4 months, 6 months, and 8 months.

19. 19. The solution of any one of claims 1 to 18 formulated as a beverage or beverage additive for human or animal consumption.

20. A beverage or beverage additive for human or animal consumption comprising a solution according to any one of claims 1 to 19.

21. 21. The beverage or beverage additive of claim 20 selected from nutritional drinks, sports drinks, functional protein drinks, dairy drinks, dairy smoothies, fruit drinks, fruit smoothies, coffee drinks, tea drinks, plant-based milks, dairy creamers, and non-dairy creamers.

22. 22. The beverage or beverage additive of claim 20 or claim 21, further comprising one or more of fruit juice, fruit juice concentrate, vegetable juice, and vegetable juice concentrate.

23. 23. The beverage or beverage additive of claim 22, wherein the composition comprises an acidic juice or juice concentrate.

24. A method for producing a solution according to any one of claims 1 to 19 or a beverage or beverage additive according to any one of claims 20 to 23, comprising the steps of: (a) adding the protein deamidase to a solution containing the protein and the stabilizer to obtain a mixture; (b) incubating the mixture; and (c) acidifying the mixture to obtain a solution having a pH of 3.5 to 7.

0.

25. 25. The method of claim 24, further comprising the step of mixing (i) the solution containing the protein and (ii) the solution containing the stabilizer prior to step (a).

26. 25. The method of claim 24, wherein the incubation is carried out at a temperature between 30° C. and 70° C. for a period between 0.5 h and 48 h, at a pH between 3.0 and 8.0, with stirring.

27. 27. The method of claim 26, wherein the incubation is carried out at a temperature between 40° C. and 60° C. for a period between 3 hours and 24 hours, at a pH between 5.0 and 8.0, and with slow stirring.

28. 28. The method of any one of claims 24 to 27, wherein the incubation is carried out until the enzymatic reaction reaches a desired level of completion, which is determined by the concentration of free ammonium ions in the solution.

29. The method of any one of claims 24 to 28, wherein the acidification comprises adding an acidic juice or juice concentrate.

30. The method according to any one of claims 24 to 29, wherein the protein deamidase has the amino acid sequence of SEQ ID NO: 1, and the incubation is performed at 50°C for 3 hours.

31. 31. The method of any one of claims 24 to 30, further comprising sterilizing the solution and subjecting it to heat treatment at 85°C for 10 minutes.

32. The method of any one of claims 24 to 31, further comprising subjecting the solution to one or more treatments selected from homogenization, pasteurization, and sterilization.

33. 33. The method of claim 32, wherein the solution is subjected to homogenization at a pressure of from 2,000 psi to 20,000 psi.

34. 33. The method of claim 32, wherein the solution is subjected to high temperature short time (HTST) sterilization at 100°C for 10 seconds to 20 seconds, ultra high temperature (UHT) sterilization at 120°C for 1 second to 3 seconds, or low temperature long time (LTLT) sterilization at 75°C to 85°C for 10 minutes to 20 minutes.

35. 33. The method of claim 32, wherein the solution is subjected to high pressure (high specific gravity) sterilization.

Images